Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda

Condition:   Malaria Interventions:   Drug: Sulfadoxine-pyrimethamine (SP);   Drug: Dihydroartemisinin-piperaquine (DP) Sponsors:   Grant Dorsey, M.D, Ph.D.;   National Institutes of Health (NIH);   Infectious Diseases Research Collaboration, Uganda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials